Fundraising FoxBraidwell — Full Portfolio
7 tracked investments · listed companies and verified rows first
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.
Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)inDavid Raben(Chief Medical Officer)in
Co-investorsAisling CapitalEight Roads VenturesF-Prime CapitalForesite CapitalPremji InvestRA Capital+6 more
Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials.
AI & Machine LearningBiotechHealthtech
David Dean Halbert(Chairman, Founder and CEO)
Co-investorsCoatue ManagementSilver Lake PartnersSixth StreetMillennium ManagementOrbiMed
Relmada is a clinical-stage biopharmaceutical company developing therapies including NDV-01, a sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, and Sepranolone, a candidate targeting compulsive behaviors via GABAA receptor modulation.
BiotechHealthtechNew York, US
Sergio Traversa(Executive Officer, Director)Paul Kelly(Director)Maged Shenouda(Director)inEliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Ence(Chief Accounting and Compliance Officer)
Co-investorsBioAdvanceBAM ElevateCommodore CapitalJanus Henderson InvestorsOrbiMedRA Capital+2 more
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in
Co-investorsAmzak HealthWellington ManagementAlgerEssex Woodlands Healthcare PartnersREDMILESands Capital Ventures+1 more
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)Noubar Afeyan(Founder)
Co-investorsAlumni VenturesCatalio Capital Management, LPDauntless VenturesFlagship PioneeringGeneral CatalystMarch Capital Partners+8 more
.png)
Nabla is a drug development company that applies design discipline and scientific rigor to the development of new medicines.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Surge Biswas(Founder)inFrances Anastassacos(Founder)inGeorge M. Church(Founder)Surge Biswas Frances Anastassacos(Founder)
Co-investorsCantos VenturesFifty YearsPetriPillar VCRadical VenturesSparta Group+6 more
Prompt is an Ambient AI product and research company that develops human-centered AI products designed to sense the physical environment.
AI & Machine LearningConsumerDeep TechSan Francisco, US
Tete Xiao(Founder)in
Co-investorsAbstract VenturesAIX VenturesDCVC (Data Collective)Neotribe VenturesAlexandriaCDP Venture Capital+4 more
Proxima develops AI-powered gaming experiences and infrastructure, with a focus on embodied AI agents and applied AI systems for interactive entertainment.
AI & Machine LearningGamingSan Francisco, US
Ran Mo(Founder)in
Co-investorsKonvoy VenturesProgressionAIX VenturesAlexandriaBalderton CapitalBayern Kapital+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.